Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2017/11/010518
CTRI/2017/11/010518CompletedPhase 4

An Open-Label, placebo controlled Study to Evaluate the Efficacy and Safety of Atosiban 6.75 mg/0.9ml in Preterm Labor

Zuventus Healthcare Limited0 sites75 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
75
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •Women =18 years of age
  • •Gestational age from 24 until 33 completed weeks which has been documented by a definite LMP or sonography in the first trimester
  • •Women with preterm labor.
  • •The diagnosis of preterm labor requires the presence of uterine contractions with or without cervical changes

Exclusion Criteria

  • •Women with any of the following:
  • •Chorioamnionitis
  • •Preterm rupture of membranes
  • •Vaginal bleeding
  • •Eclampsia and severe pre-eclampsia requiring delivery
  • •Intrauterine growth restriction
  • •Intrauterine fetal death
  • •Congenital or acquired uterine malformation
  • •Severe placental insufficiency
  • •Placenta previa and abruptio placentae
  • •Fetal distress
  • •Women who are otherwise judged inappropriate for inclusion in the study by the investigator.

Investigators

Similar Trials

Completed
Not Applicable
A randomised open label placebo study to evaluate the use of Solcogyn applied topically to the cervix in women referred for the assessment of cervical low grade intro-epithelial lesions
ISRCTN06133220Department of Health (UK)106
Completed
Phase 4
To determine the clinical effectiveness and safety of a local application of Inj Reptilase in patients with bleeding of respiratory and upper digestive tract
CTRI/2008/091/000208Troikaa Pharmaceuticals Limited60
Recruiting
Phase 2
An open-label, randomized controlled study evaluating the effectiveness of Pramipexole extended-release tablets for tardive dystonia patientsTardive dystoniaDrug-induced extrapyramidal syndromeG240
JPRN-jRCTs031180316Iyo Masaomi24
Recruiting
Phase 2
An open-label, randomized controlled study evaluating the effectiveness of pramipexole extended-release tablets for tardive dystonia.Tardive dystonia
JPRN-UMIN000014988Department of Psychiatry, Chiba University Graduate School of Medicine24
Active, not recruiting
Phase 4
To study the effect of Probiotics Bacillus subtilis on Diarrhoea due to antibiotics
CTRI/2018/01/011186Synergia Life Sciences Pvt Ltd